BioSpace News Archive

Deals

MorphoSys AG Reports Outcome of Annual General Meeting 2019

All Resolutions Proposed by the Company’s Management Approved

May 23, 2019
·
5 min read
Business

BioArctic strengthens its blood-brain barrier technology platform with world leading scientist recruitment

BioArctic AB announced that the company has recruited the internationally renowned scientist Dr. Per-Ola Freskgård to strengthen BioArctic’s development of its technology platform to facilitate passage of antibodies and other biologics across the blood-brain barrier.

May 23, 2019
·
3 min read
Policy

Molecules Swing Electrolytes across Membranes to Kill Cancer Cells

Researchers from Singapore have designed the world’s first ‘molecular swing’ to transport electrolytes across cell membranes.

May 23, 2019
·
5 min read
Business

Medigene AG: Medigene announces clinical trial agreement for HA-1 TCR immunotherapy MDG1021 with University of Leiden

Medigene AG announced that it entered into a Clinical Trial Agreement with the Leiden University Medical Center, the Netherlands, to conduct a Phase I clinical trial with Medigene’s T cell receptor modified T cell therapy MDG1021 targeting the HA-1 antigen.

May 23, 2019
·
3 min read
Deals

Lab Notebook learns to communicate with laboratory devices: labfolder acquires cubuslab and becomes Labforward

labfolder GmbH from Berlin and the cubuslab GmbH from Karlsruhe are merging.

May 23, 2019
·
5 min read
Micronic Leading the Industry with Sustainable Sample Storage Products

Micronic has joined an elite group of manufacturers committed to product transparency and sustainable procurement.

May 23, 2019
·
2 min read
Medigene AG: Medigene AG reports on Annual General Meeting 2019

Martinsried/Munich Medigene AG, a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, reports on the Company’s Annual General Meeting which was held in Munich.

May 23, 2019
·
3 min read
Deals

Pharming Reports On Annual General Meeting Of Shareholders

Pharming Group N.V. announces that at its Annual General Meeting of shareholders, all proposals were approved.

May 23, 2019
·
3 min read
Business

Bayer Makes Global Impact Through World Federation of Hemophilia Humanitarian Aid Program

In addition to education and training, it will offer Bayer’s complete portfolio of recombinant Factor VIII treatments to healthcare providers in more than 60 countries.

May 23, 2019
·
2 min read
·
Mark Terry
Business

BioSpace Movers and Shakers, May 24

Biopharma companies from across the globe strengthen their leadership teams with key executive appointments.

May 23, 2019
·
5 min read
·
Alex Keown